All University of Alabama articles
-
NewsCaffeine-degrading microbes could tackle coffee pollution - and produce valuable pharmaceutical compounds
Caffeine-degrading microbes could offer vital bioremediation services as well as upcycling coffee waste into valuable pharmaceutical compounds, a new review suggests.
-
NewsBreastfeeding after COVID-19 booster can give babies antibodies
Lactating mothers who get the COVID-19 booster pass along the antibodies to their children via their breast milk – and potentially protect babies too young to receive the vaccine.
-
NewsAntibiotic is cost-saving treatment for reducing maternal sepsis in developing countries
New findings suggest that giving an oral dose of azithromycin to pregnant women who deliver vaginally is a cost-saving treatment for reducing maternal sepsis, death or infection in developing countries.
-
NewsPotential therapeutic target found to combat TB, a disrupted NAD(H) homeostasis
A study shows how Mycobacterium tuberculosis perturbs homeostasis of the high-energy molecule NADH and reprograms glycolysis in myeloid cells - highlighting glycolysis as a potential therapeutic target.
-
NewsAntimicrobial peptides modulate lung injury by altering the intestinal microbiota
Researchers have identified a gut-lung axis driven by intestinal antimicrobial peptide expression and mediated by the intestinal microbiota that is linked to lung injury in newborns.
-
NewsResearchers ID genes that correlate with early colonization in fecal microbe transplants
Researchers found 19 Bacteroides vulgatus genes that were unique to three strains that show early engraftment in patients after a fecal transplant, as opposed to seven strains that did not show early engraftment.
-
NewsVaccine primes frog microbiome for future exposure to deadly fungal outbreak
A new study has found that a new vaccine against the deadly chytrid fungus in frogs can shift the composition of the microbiome, making frogs more resilient to future exposure to the fungus.
-
NewsPotential drug takes aim at emerging Chikungunya virus
Researchers are developing what could become the first-ever treatment against the debilitating joint pain that can last months or years after becoming infected with the emerging Chikungunya virus.
